AbbVie Inc - Company Profile
Powered by
All the data and insights you need on AbbVie Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date AbbVie Inc Strategy Report
- Understand AbbVie Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on AbbVie Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
01 Aug 2022 | AbbVie Enters into Licensing Agreement with Sosei Heptares (Sosei) | Licensing Agreement |
AbbVie Inc
|
Sosei Group Corp |
20 Jul 2022 | AbbVie and iSTAR Medical Enter into Partnership | Partnership | - |
AbbVie Inc
iSTAR Medical SA
|
14 Jul 2022 | Oncternal Therapeutics Enters into Collaboration with Pharmacyclics | Partnership | - |
Pharmacyclics LLC
Oncternal Therapeutics
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward